Jiangrui Chi
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Routine biomarkers map response probability in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2 blockade.
Journal: BMC cancer
Published: May 28, 2026
Resolving tumor microenvironment heterogeneity to forecast immunotherapy response in triple-negative breast cancer through multi-scale analysis.
Journal: Frontiers in oncology
Published: December 03, 2024
DNA methylation profiling deciphers three EMT subtypes with distinct prognoses and therapeutic vulnerabilities in breast cancer.
Journal: Journal of Cancer
Published: March 08, 2024
Catheter malposition analysis of totally implantable venous access port in breast cancer patients.
Journal: Frontiers in surgery
Published: October 05, 2022
Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer.
Journal: Journal of inflammation research
Published: January 05, 2022
Identification of novel prognostic risk signature of breast cancer based on ferroptosis-related genes.
Journal: Scientific reports
Published: December 14, 2021
Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases.
Journal: Frontiers in oncology
Published: June 22, 2021
Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics.
Journal: Frontiers in genetics
Published: June 07, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026